Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Samuel Isaly‘s hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier. Following the decline in holdings, Orbimed’s position amasses 4.73% of NxStage’s common stock, versus 5.25% reported in an earlier filing.

NxStage Medical, Inc. (NASDAQ:NXTM)

Disclosure: none

Recommended Reading:

Steven Cohen, SAC Capital Boost Position in Vitamin Shoppe

Baker Bros. Decreases Exposure at Viropharma

Earnest Partners Decreases Position in Astoria Financial Corp; Ups Stake in Meritage Homes Corp

Loading...